Advancing Post-Market Surveillance of High-Risk Facilities and Products through Signal detection, Data analysis, and the Review of the State of Quality (U01) Clinical Trial Optional

Archived

Food and Drug Administration

Description

The purpose of this program is to advance comprehensive quality surveillance and provide the state of quality for all regulated sites and products. Using predictive analytics, data mining, and other quantitative tools, this research program will expand the knowledge base related to site and product quality, especially for high-risk foreign facilities and their products

Who can apply

  • State governments
  • County governments
  • City or township governments
  • Special district governments
  • Independent school districts
  • Public and State controlled institutions of higher education
  • Native American tribal governments (Federally recognized)
  • Native American tribal organizations (other than Federally recognized)
  • Nonprofits with 501(c)(3) status (other than higher education)
  • Nonprofits without 501(c)(3) status (other than higher education)
  • Private institutions of higher education
  • For-profit organizations other than small businesses
  • Small businesses
  • Others

Contact

Shashi Malhotra <br/>Grants Management Specialist <br/>Phone 2404027592
shashi.malhotra@fda.hhs.gov

Key dates & funding
  • PostedFeb 26, 2019
  • ClosesApr 5, 2021
  • Award floor$750,000
  • Award ceiling$2,500,000
  • Program funding$4,500,000
  • Expected awards2
  • CFDA93.103

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro